Physician profile
Lorrie M Kenseth
NPI 1306030747
$7,390.41
in general payments reported to CMS, 2019-2025
24 companies · $3,353 in 2025
The $3,353 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,128 · 2022: $104 · 2023: $1,666 · 2024: $1,140 · 2025: $3,353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,873 · Travel and Lodging: $2,123 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,872.89 |
| Travel and Lodging | $2,123.44 |
| Education | $162.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,344.27 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $1,051.75 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept, Superion Indirect Decompression System |
| Si-Bone, INC. | $398.48 | 2025 | |
| Abbott Laboratories | $292.37 | 2023-2025 | Eterna, Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $216.40 | 2021-2025 | Relistor |
| Spr Therapeutics, INC | $214.85 | 2023-2025 | Sprint Pns System |
| Abbvie INC. | $205.91 | 2021-2025 | |
| Edwards Lifesciences Corporation | $135.38 | 2025 | Sapien 3 Ultra Resilia |
| Vertos Medical, INC. | $81.17 | 2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $71.39 | 2025 | Evoke |
| Biodelivery Sciences International, INC. | $52.07 | 2021 | |
| Inspire Medical Systems, INC. | $50.13 | 2025 | Inspire |
| Averitas Pharma INC. | $41.24 | 2023 | Qutenza |
| Allergan, INC. | $37.48 | 2021 | |
| Amneal Pharmaceuticals LLC | $34.07 | 2023 | Lyvispah |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $25.86 | 2025 | |
| Lundbeck LLC | $20.99 | 2024 | Vyepti |
| West Therapeutics Development, LLC | $19.71 | 2021 | |
| Kci USA, INC. | $19.12 | 2022 | |
| Azurity Pharmaceuticals, INC. | $18.39 | 2025 | Horizant |
| Curonix LLC | $17.98 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Novartis Pharmaceuticals Corporation | $14.44 | 2021 | |
| Pacira Therapeutics, INC. | $13.56 | 2021 | |
| Painteq LLC | $13.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorrie Kenseth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.